Figures & data
Figure 1. %inhibition of C. albicans biofilm (24 h) at different concentrations of Ag NPs. Error bars represent % error.
Figure 2. (A) Reduction in metabolic activity of Candida albicans (n = 25) biofilm after treatment with mycogenic AgNPs at 24 h by XTT assay. Error bars represent standard deviation from the mean. (B) Reduction in metabolic activity (%age) of non-albicans spp. (n = 20) biofilm (24 h) after treatment with mycogenic AgNPs by XTT assay. Error bars represent standard deviation from the mean.
Figure 3. (A) Effect of mycogenic AgNPs on the secreted aspartyl proteinase activity of clinical isolates of biofilm forming C. albicans (24 h). Error bar represents %age error. (B) Effect of mycogenic AgNPs on the secreted aspartyl proteinase activity of clinical isolates of biofilm forming C. albicans (48 h). Error bar represents %age error.
Figure 4. (A) Effect of mycogenic AgNPs on the secreted aspartyl proteinase activity of clinical isolates of biofilm (24 h) forming non-albicans spp. Error bars showed %age error. (B) Effect of mycogenic AgNPs on the secreted aspartyl proteinase activity of clinical isolates of biofilm (48 h) forming non-albicans spp. Error bars showed %age error.
